Clinical Trials Update: March 13, 2008
Bladder Disorders
Metastatic Melanoma
Migraine and Cluster Headaches
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Bladder Disorders
If you are 18 or older and have urinary incontinence due to an overactive bladder, you may qualify for this 14-week, five-visit study.
The research site is in Charlottesville, Va.
More information
Please see http://www.centerwatch.com/patient/studies/cat445.html 
.
-----
Metastatic Melanoma
To qualify for this study, candidates be at least 18, have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, have measurable disease according to modified RECIST, and have a life expectancy of more than 12 weeks.
The research site is in Tucson, Ariz.
More information
Please see http://www.centerwatch.com/patient/studies/cat723.html .
-----
Migraine and Cluster Headaches
If you are aged 18 to 65, are not pregnant, have had at least one migraine attack per month in the last three months, and have an active prescription for a butalbital-containing medication, you may qualify for this study.
The research site is in Bronx, N.Y.
More information
Please see http://www.centerwatch.com/patient/studies/cat100.html .
-----
Copyright 2008 Thomson CenterWatch . All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved. 
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.